Pfizer (PFE) Tops Q4 EPS by 20c, Revenue Misses, Guidance Falls Short of Views

Pfizer (NYSE: PFE) reported Q4 EPS of $1.08, $0.20 better than the analyst estimate of $0.88. Revenue for the quarter came in at $23.8 billion versus the consensus estimate of $24.17 billion.

GUIDANCE:

Pfizer sees FY2022 EPS of $6.35-$6.55, versus the consensus of $6.65. Pfizer sees FY2022 revenue of $98-102 billion, versus the consensus of $106.5 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)
• LEEF Brands appoints Hirsh Jain to board as independent director